TWIST enhances the metastatic potential of prostate cancer and promotes cancer progression through epithelial–mesenchymal transition (EMT), the expression of dickkopf homolog 1 (DKK-1), and enhancing osteomimicry of prostate cancer cells [221]. Here, TWIST1 is linked to prostate cancer.